Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Pulmonary Sarcoidosis (Single-Arm Phase 2)
2019-000580-24Phase 2Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azithromycin in sarcoidosis, sponsored by Hull University Teaching Hospitals. Primary endpoint: Automated cough counting. Started Mar 2019; status: terminated.
02
Drugs
azithromycin
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on 2019-000580-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000580-24.